TissGeneSummary for FSCN3 |
Gene summary |
Basic gene information | Gene symbol | FSCN3 |
Gene name | fascin actin-bundling protein 3, testicular | |
Synonyms | - | |
Cytomap | UCSC genome browser: 7q31.3 | |
Type of gene | protein-coding | |
RefGenes | NM_020369.2, | |
Description | fascin homolog 3, actin-bundling protein, testicularfascin-3testis fascin | |
Modification date | 20141207 | |
dbXrefs | MIM : 615800 | |
HGNC : HGNC | ||
Ensembl : ENSG00000106328 | ||
HPRD : 17020 | ||
Vega : OTTHUMG00000022935 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_FSCN3 | |
BioGPS: 29999 | ||
Pathway | NCI Pathway Interaction Database: FSCN3 | |
KEGG: FSCN3 | ||
REACTOME: FSCN3 | ||
Pathway Commons: FSCN3 | ||
Context | iHOP: FSCN3 | |
ligand binding site mutation search in PubMed: FSCN3 | ||
UCL Cancer Institute: FSCN3 | ||
Assigned class in TissGDB* | B | |
Included tissue-specific gene expression resources | HPA,TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of FSCN3 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for FSCN3 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for FSCN3 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for FSCN3 |
TissGeneSNV for FSCN3 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.R394C | SKCM | 2 |
p.S127F | SKCM | 2 |
p.V172F | LUAD | 1 |
p.H100Y | LUSC | 1 |
p.R154H | STAD | 1 |
p.C456S | BLCA | 1 |
p.F198L | PAAD | 1 |
p.R101W | KIRC | 1 |
p.P173S | SKCM | 1 |
p.G232V | LUAD | 1 |
p.G80C | LUAD | 1 |
p.M163I | LUAD | 1 |
p.G434E | HNSC | 1 |
p.A62V | SKCM | 1 |
p.G433R | LGG | 1 |
p.R65X | UCS | 1 |
p.D281N | STAD | 1 |
p.G80A | SKCM | 1 |
p.V284E | LUAD | 1 |
p.R392* | UCS | 1 |
p.R252S | STAD | 1 |
p.R220W | STAD | 1 |
p.A41S | LUAD | 1 |
p.R185* | UCEC | 1 |
p.I417T | LUAD | 1 |
p.P173R | PRAD | 1 |
p.A170T | LUAD | 1 |
p.V123M | STAD | 1 |
p.D122G | STAD | 1 |
p.L389F | SKCM | 1 |
p.F357L | BRCA | 1 |
p.R311C | UCS | 1 |
p.E458K | HNSC | 1 |
p.E231* | OV | 1 |
p.L199F | HNSC | 1 |
p.R285C | PRAD | 1 |
p.N369S | STAD | 1 |
p.Y474H | LGG | 1 |
p.W136X | SKCM | 1 |
p.R446H | COAD | 1 |
p.R269K | SKCM | 1 |
p.W136* | SKCM | 1 |
p.R165C | STAD | 1 |
p.Q314K | LUAD | 1 |
p.R285C | UCEC | 1 |
p.R86C | PRAD | 1 |
p.F198L | UCEC | 1 |
p.G380V | LUAD | 1 |
p.Y156H | PRAD | 1 |
p.R65* | UCS | 1 |
p.P237S | HNSC | 1 |
p.R98H | LGG | 1 |
p.R446C | SKCM | 1 |
p.R101Q | BLCA | 1 |
p.R285C | STAD | 1 |
p.W50* | SKCM | 1 |
p.R139L | LUAD | 1 |
p.D415N | SKCM | 1 |
p.E497K | SKCM | 1 |
p.E334K | READ | 1 |
p.R356H | PAAD | 1 |
p.H190Y | SKCM | 1 |
p.A469V | STAD | 1 |
p.H241Y | UCEC | 1 |
p.R293* | HNSC | 1 |
p.Q411H | LUAD | 1 |
p.N344I | STAD | 1 |
p.P334A | THYM | 1 |
p.N119D | SKCM | 1 |
p.E378K | SKCM | 1 |
p.R114H | PRAD | 1 |
p.W50X | SKCM | 1 |
p.A170T | BLCA | 1 |
p.C155* | UCEC | 1 |
p.D281N | COAD | 1 |
p.S462C | LUAD | 1 |
Top |
TissGeneCNV for FSCN3 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for FSCN3 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for FSCN3 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for FSCN3 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for FSCN3 |
TissGeneDrug for FSCN3 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for FSCN3 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |